KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressCurrent Deferred RevenueDividends payablesLand & ImprovementsLiabilities and Shareholders EquityLoans - NetMinority InterestOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Current Deferred Revenue (2016 - 2025)

Historic Current Deferred Revenue for National Health Investors (NHI) over the last 17 years, with Q3 2025 value amounting to $4.0 million.

  • National Health Investors' Current Deferred Revenue fell 1283.61% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year decrease of 1283.61%. This contributed to the annual value of $4.3 million for FY2024, which is 2882.34% down from last year.
  • Per National Health Investors' latest filing, its Current Deferred Revenue stood at $4.0 million for Q3 2025, which was down 1283.61% from $4.1 million recorded in Q2 2025.
  • In the past 5 years, National Health Investors' Current Deferred Revenue ranged from a high of $11.0 million in Q1 2021 and a low of $4.0 million during Q3 2025
  • In the last 5 years, National Health Investors' Current Deferred Revenue had a median value of $5.1 million in 2022 and averaged $5.5 million.
  • Per our database at Business Quant, National Health Investors' Current Deferred Revenue plummeted by 6094.6% in 2022 and then soared by 2340.03% in 2023.
  • National Health Investors' Current Deferred Revenue (Quarter) stood at $5.7 million in 2021, then decreased by 11.76% to $5.1 million in 2022, then rose by 18.94% to $6.0 million in 2023, then decreased by 28.82% to $4.3 million in 2024, then decreased by 6.01% to $4.0 million in 2025.
  • Its last three reported values are $4.0 million in Q3 2025, $4.1 million for Q2 2025, and $4.1 million during Q1 2025.